Literature DB >> 5705237

Selective blockade by mephentermine of reserpine-induced serotonin depletion.

J E Fitzwater, R P White, C B Nash.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5705237     DOI: 10.1007/bf02138322

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  7 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  Evidence that tranquilizing action of reserpine is associated with change in brain serotonin and not in brain norepinephrine.

Authors:  B B BRODIE; K F FINGER; F B ORLANS; G P QUINN; F SULSER
Journal:  J Pharmacol Exp Ther       Date:  1960-07       Impact factor: 4.030

3.  STRESS-INDUCED RELEASE OF BRAIN NOREPINEPHRINE AND ITS INHIBITION BY DRUGS.

Authors:  E W MAYNERT; R LEVI
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

4.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

5.  Acute ergotropic response induced by reserpine and mephentermine.

Authors:  R P White; D P Cobb; G R Breese; C B Nash
Journal:  Int J Neuropharmacol       Date:  1966-03

6.  A sensitive and specific fluorescence assay for tissue serotonin.

Authors:  S H Snyder; J Axelrod; M Zweig
Journal:  Biochem Pharmacol       Date:  1965-05       Impact factor: 5.858

7.  Electrographic evidence of indirect central actions of reserpine and mephentermine.

Authors:  R P White
Journal:  Arch Int Pharmacodyn Ther       Date:  1966-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.